Cubicin (daptomycin for injection)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
Post-Marketing Experience
Addition of the following adverse reactions:
Blood and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts